Cargando...
Multiple sclerosis and COVID‐19: How many are at risk?
BACKGROUND AND PURPOSE: The coronavirus disease 2019 (COVID‐19) pandemic challenges neurologists in counseling multiple sclerosis (MS) patients with respect to their risk for and by severe acute respiratory syndrome coronavirus 2 and in guiding disease‐modifying treatment (DMT). The objective was to...
Guardado en:
| Publicado en: | Eur J Neurol |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537184/ https://ncbi.nlm.nih.gov/pubmed/32978860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.14555 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|